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Abstract: Four 3H-spiro1-benzofuran-2, 1’-cyclohexanes were synthesized from filifolinol, two of which are reported for the first time.  
Docking molecular studies were carried out to determine in silico whether these derivatives have similar immunostimulant activity to that 
reported for filifolinol, and its oxidation product, filifolinone. Through of the study of interactions of these compounds with the heterodimer 
of the protein present in teleost TLR1-TLR2, filifolinol, 3’-filifolinchloride and filifolinyl acetate shows similar interactions between them, 
allowing to predict that they would have similar immunostimulant activity, but different to filifolinone and filifolinane or that they would act 
by a different mechanisms. 
 
Keywords: 3H-spiro1-benzofuran-2, 1’-cyclohexanes, filifolinol (1), molecular docking immunostimulant activity. 
 
 
 
 
 
 
RESUMEN: Cuatro 3H-spiro1-benzofuran-2, 1'-ciclohexanos se sintetizaron a partir de filifolinol, dos de los cuales son reportados por 
primera vez. Se llevaron a cabo estudios de docking molecular para determinar in silico si estos derivados tienen actividad inmunoestimu-
lante similar a la reportada para filifolinol y su producto de oxidación, filifolinona. A través del estudio de las interacciones de estos com-
puestos con el heterodímero de la proteína presente en teleósteos TLR1-TLR2 se estableció que el filifolinol, 3'-cloruro de filifolinilo y 
acetato de filifolinilo tienen interacciones similares con el heterodímero, lo que permite predecir que entre ellos tendrían una actividad simi-
lar, pero diferente a la de la filifolinona y filifolinano o que estos últimos actuarían por diferentes mecanismos. 
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INTRODUCTION 
Currently, the control of infectious diseases caused 
by viruses and bacteria that attack food-producing 
animals is focus on the use of antibiotics. However, 
the use of such drugs has generated great concern 
because the potential risk of emergence and spread of 
resistant organisms, as well as the generation of toxic 
waste, in products for human consumption and the 
environment (Rosenblatt-Farrell, 2009). Alternative-
ly, many current researches consider the development 
of new pharmacological tools to stimulate the im-
mune response. 
 Aquaculture is an export sector of great im-
portance in Chile, which has been affected by major 
economic losses due to the occurrence of several 
emerging infectious diseases. These diseases can be 
optionally controlled using vaccines; however, one 
important limitation in the design of vaccines in this 
sector is the lack of immunostimulants and / or adju-
vants to generate a good immune response. 
 On the other hand, the use of vaccines is lim-
ited in salmon fingerlings due to its small size and 
immaturity of their immune system, which prevents 
an adequate response. Therefore, to combat infectious 
diseases in salmons is necessary to develop new 
pharmacological tools to stimulate immune respons-
es. 
 Heliotropium filifolium is a resinous bush that 
grows in desert environments and is characterized by 
the production of resin that covers their leaves and 
stems; as defence mechanism against adverse envi-
ronmental conditions. Phytochemical studies of this 
species have shown that the resin is formed by minor 
amounts of flavonoids and large amounts of a series 
of unusual 3H-spiro1-benzofuran-2, 1’-cyclohexanes 
derivatives of mixed biosynthesis (Torres et al., 
1994; Urzúa et al., 2001; Urzúa et al., 2008). 
 Among the 3H-spiro 1-benzofuran-2, 1'-
cyclohexanes derivatives, filifolinol (1), is by far the 
main component of this fraction. Early unpublished 
immunostimulant studies of filifolinol (1), evaluated 
through activation of lymphocytes in splenocytes and 
in dendritic cells of mouse bone marrow, showed that 
at a concentration of 10 mg/mL, filifolinol (1) was 
able to induce a significant increase in the percentage 
of dendritic cells (80%) and in lymphocytes T CD8 a 
150% in relation to control.  
 Recent studies proposed the oxidation deriva-
tive of filifolinol (1); filifolinone (2), as a good can-
didate for studies of immunostimulant activity in 
vivo, since this compound increases the expression of 
MHC molecules class II promoting maturation of 
dendritic cells (Modak et al., 2012). Also, the im-
munomodulatory effects of filifolinone (2) were stud-
ied in vitro using the SHK-1 cell line derived from 
leucocytes of salmon kidney head and in vivo in At-
lantic salmon. For the study, the effect of this com-
pound was evaluated in the expression of various 
cytokines. The results showed that filifolinone (2) 
increases the levels of expression of pro-
inflammatory and anti-inflammatory cytokines. This 
suggests that filifolinone (2) is a potential alternative 
immunomodulator for veterinary uses (Valenzuela et 
al., 2013). 
 In searching for new filifolinol (1) deriva-
tives, with immunostimulatory activity two new 
compounds were synthesized. They correspond to 
filifolinane (3) and filifolinchloride (4) with structural 
variations in the C-3' of ring C. In addition, molecular 
docking studies were performed between toll-like 
receptors TLR2-TLR1 heterodimer and compounds 
(1-5),to establish a structure-immunostimulant activi-
ty relationship.  
 
MATERIALS AND METHODS 
Plant material 
Heliotropium filifolium (Miers) Reiche was collected 
during the flowering season in Carrizal Bajo, Chile 
(III Region 28º 45' S, 70º 49' W) and identified by Dr. 
Sebastián Teiller.  
 Voucher specimens (ST-2214 SSCU) were 
deposited in the Herbarium of the Faculty of Biologi-
cal Sciences of Catholic University of Chile, Santia-
go, Chile. 
 
Extraction and isolation of Filifolinol (1) 
The resin was obtained by immersion of the fresh 
plant in dichloromethane for 30-60 s at room temper-
ature. The solvent was evaporated and the extract 
fractionated by column chromatography using hex-
ane- ethyl acetate step gradient yielding filifolinol (1) 
(Urzua et al., 2001).  
 
Filifolinone (2) 
Filifolinone (2) was obtained from filifolinol (1) by 
conventional oxidation with CrO3 and was purified 
by column chromatography using benzene-ethyl ace-
tate (Torres et al, 2002).  
 
Filifolinane (3) 
Filifolinol (1) (1g) dissolved in dichloromethane (5 
mL) with 0.5 mL of N, N-dimethylformamide and 
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2.5 mL of thionyl chloride was  refluxed for 1 h. The 
solvent was removed from the cold reaction mixture 
to give brown oil. After purification of the oil by 
column chromatography, using hexane- ethyl acetate 
step gradient, a pure white crystalline solid was ob-
tained (yield, 50%). (mp 96-97ºC). []21D: +1.09; IR 
(nujol) υ max cm
-1
:1716; 
1
H-NMR see Table 1. 
 
3’-Filifolinchloride (4)  
Filifolinol (1) (1 g) dissolved in dichloromethane (5 
mL) with 0.25 mL of pyridine was placed in a cold 
water bath. Thionyl chloride (2.5 mL) was added 
quickly and the mixture genteelly refluxed for 8 h. 
The cold reaction mixture was treated with 5mL of 
distilled water, extracted with diethyl ether and the 
extract was dried with anhydrous calcium chloride, 
filtered and the solvent removed to give a brown 
amorphous solid. After purification of the solid by 
column chromatography, using dichloromethane, a 
pure crystalline solid was obtained (yield, 13%) (mp 
111-112ºC). []21D: - 15.53; IR (nujol) υ max cm
-1
: 
1720, 666;  
1
H-NMR see Table 1. 
 
filifolinyl acetate (5) 
Filifolinol (1) (2g) dissolved in 3 mL of acetic anhy-
dride, with 0.4 mg of N, N-dimethylaminopyridine 
was stirred for 13 h at room temperature. The cold 
reaction mixture was treated with 5mL of distilled 
water, extracted with diethyl ether and the extract 
was dried with anhydrous calcium chloride, filtered 
and the solvent removed to give a brown amorphous 
solid.  The solid was purified by preparative thin 
layer chromatography using hexane- ethyl acetate 
9:1, a pure white crystalline solid was obtained 
(yield, 45%) (mp 127-128ºC). []21D: - 4.69; IR (nu-
jol) υ max cm
-1
: 1730, 1711;  
1
H-NMR see Table 1. 
 
Structural Determination 
Melting points were determined on Kofler micro 
melting apparatus and are uncorrected. Optical rota-
tions were measured on Perkin Elmer 241 polarime-
ter. IR spectra were obtained in Nujol on a Bruker 
IFS 66v instrument. 
1
HNMR (400 MHz) spectra were 
recorded in CDCl3 on Bruker Avance DRX400 spec-
trometer with TMS as internal standard. Filifolinol 
(1), filifolinone (2) and filifolinyl acetate (5) were 
identified by comparison of their spectroscopic data 
with those reported in the literature (Torres et al., 
2002; Urzúa et al., 2008)  and by TLC co-
chromatography with authentic samples. 
 
Molecular docking  
All structures were built with the Gaussian view 
software. Restrained electrostatic potential (RESP) 
charges were obtained at the B3LYP/6-31G** level 
of theory employing the Gaussian 03 package 
(Frisch et al., 2004) Docking studies was released 
between compounds 1-5 and crystal structure of Toll-
like receptor TLR2-TLR1 heterodimer (PDB ID: 
2Z81) at 1.8 Å of resolution was performed the Au-
toDock4 package (Morris et al., 1998) using a La-
marckian algorithm and assuming total flexibility of 
3H-spiro1-benzofuran-2,1’-cyclohexanes  and partial 
flexibility of protein. The grid maps were made up of 
60 x 60 x 60 points, with a grid-point spacing of 
0.375 Å. The AutoTors option was used to define the 
ligand torsions and the docking results were then 
analyzed by a ranked cluster analysis, resulting in 
conformations with the highest overall binding ener-
gy (most negative-ΔG binding value). All the dock-
ing results were analyzed in VMD software (Phillips 
et al., 2005). 
 
RESULTS AND DISCUSSION 
Synthesis and identification of compounds   
Because filifolinol (1) and in particular filifolinone 
(2), have shown interesting immunostimulating activ-
ity, looking to increase these activity, three com-
pounds were synthesized with different substitution at 
C-3'. In order to modify the C-3'-OH of filifolinol (1), 
a reduction, chlorinated and acylated derivatives. The 
reduced and chlorinated compounds are reported for 
first time. 
 The IR spectra of compound 3 shows one 
intense peak at 1716 cm
-1
 assigned to the C=O 
stretching of the aromatic ester. The characteristic 
signal at 3500 cm
-1
 -OH in position 3’ of starting 
compound filifolinol (1), is not observed indicating 
the substitution of the C-3’-hydroxyl group by -H. 
Finally, the 
1
H-NMR spectrum (Table 1) was close 
similar to that of filifolinol (1)  except for the signals 
of protons in C-3, shifted to lower field (δ 5.34, 5.47; 
J= 9.7 Hz) and a broad singlet at  δ 3.01 (2H) corre-
sponding to the protons attached to C-3’.   
 The IR spectrum of compound 4 showed two 
intense peaks at 1720 cm
-1
 assigned to the C = O 
stretching of an aromatic ester and 666 cm
-1
 assigned 
to the C-Cl stretching of an aliphatic chloride. In 
agreement with the replacement of the hydroxyl 
group for –Cl, the characteristic signal at 3500 cm-1 
of C-3'-OH of filifolinol (1), was not observed. The 
reaction of filifolinol (1) with thionyl chloride and 
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pyridine occurs via an SN2 mechanism (Smith, 2013) 
and produce inversion of the configuration at C-3’, 
leaving the -Cl in equatorial position, and the C-3’-H 
in axial position. Finally, the 1H-NMR spectrum 
(Table 1) was very similar to that of filifolinol (1), 
except for the signal at δ 3.69 m C-3'-H (eq) of filifoli-
nol (1) shifted to δ 4.03 m C-3'-H(ax),  due to the  
magnetic effect produced by the geminal  Cl and the 
axial position. 
 
 
Figure 1 
 
 
 
 
 
Table 1 
1
H-NMR data of compounds 1-5 
 
C-H (1) (2) (3) (4) (5) 
C-7-H 6.70 6.76 6.75 7.28 6.72 
C-6-H 7.81 7.86 7.84 6.71 7.83 
C-4-H 7.79 7.79 7.80 7.84 7.81 
OMe 3.84 3.86 3.86 3.86 3.86 
C-3-Hα 3.62 2.78 5.47 3.47 3.48 
C-3-Hβ 3.04 2.95 5.34 3.04 3.07 
C-6’-H(ax) 2.28 2.30 2.26 2.28 2.31 
C-6’-Me(eq) 0.78 0.90 0.72 0.79 0.78 
C-5’-H(ax) 1.38 1.32 1.86 1.97
a 
1.46 
C-5’-H(eq) 1.52 1.92 2.55 1.97
a
 1.51 
C-4’-H(ax) 1.61 2.72 1.56
a 
1.98
a
 1.66 
C-4’-H(eq) 1.97 2.76 1.56
a
 1.98
a
 1.91 
C-3’-H(eq) 3.69 (m) - 3.01
b 
(br s) - 4.85 (br t, J= 2.8) 
C-3’-H(ax) - - 3.01
b
 (br s) 4.03(m) - 
C-2’-Me(eq) 1.45 1.34 1.22 1.22 1.22 
C-2’-Me(ax) 1.02 0.94 0.88 0.99 0.93 
Ac-Me - - - - 2.31 
a
 two hydrogens 
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Molecular docking 
From the analyzed conformations, present interac-
tions between filifolinol (1) and their derivatives with 
amino acids residues of the TLR1-TLR2 heterodimer 
were evaluated. 
 The docking results showed that filifolinol 
(1), 3’- filifolinchloride (4), filifolinone (2) and fili-
foly acetate (5) had non-covalent interactions with 
residues of the TLR2 segment. However, the filifoli-
nane (3) interacted only with TLR1 segment. In addi-
tion, it was found that filifolinol (1) shown hydrogen 
bond between the hydroxyl and VAL-348 and π 
stacking with PHE-325. On the other hand, none 
interaction hydrogen bond or π stacking was ob-
served between filifolinone (2) and TLR2 segment. 
The docking showed that filifolinone (2) had affinity 
with the TLR1 segment (figure 2), and the most in-
teresting interactions were Van der Waals and π 
stacking with TYR-376 of TLR2 segment. Finally, 
3’- filifolinchloride (4), filifolinone (2) and filifolyn 
acetate (5) , showed interactions with TLR1 segment. 
In addition, filifolyn acetate (5) showed hydrogen 
bond interaction between C-3’-acyl group and the 
hydroxyl group of PHE-325. Table 2 shows a sum-
mary of interactions found between compounds (1-5) 
and residues of the heterodimer. 
 
 
 
Figure 2  
Main filifolinone (2)-TLR1 interactions. 
 
_______________________________________________ 
 
Table 2 
Summary of the most relevant interactions of compounds (1-5). 
 
filifolinol(1) filifolinone(2) filifolinane(3) 3filifolinchloride(4) filifolyn acetate (5) 
ILE 319* LEU 273 TRP 258** ILE 319* ILE 319* 
PHE 325* ASN 274 SER 309* PHE 325* PHE 325* 
LEU 328 ASP 305 PHE 312** LEU 328 TYR 326 
LYS 347 VAL 309* ILE 319* VAL 343* LEU 328 
VAL 348* LEU 312 TYR 320** LYS 347 VAL 343* 
PHE 349* LEU 334 THR 336* VAL 348* VAL 348* 
LEU 350*  ARG 337* PHE 349* PHE 349* 
VAL 351  MET 338** LEU 350* LEU 350*. 
LEU 355*  TYR 376 VAL 351  
LEU 367   LEU 359  
   LEU 365  
   LEU 367  
   TRP 386  
* TLR1 amino acid residues. 
** Reported residues for TLR1-TLR2 heterodimer (Jin et al., 2007) 
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CONCLUSION 
The in silico ligand-receptor study shows that are 
common interactions between filifolinol (1), 3’-
filifolinchloride (4) and filifolyn acetate (5) with the 
heterodimer TLR1-TLR2. This allows to predict that 
these compounds should be similar immunostimulant 
activity among them and different to filifolinone (2) 
or act by different mechanisms. In the same way, 
filifolinane (3), would have a totally different activity 
of filifolinol (1) and their derivatives. 
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